-
Projected Rapid-Growing Economic Burden of Chronic Respiratory Multimorbidity in Singapore: Unveiling Diagnostic Gaps and Asian Phenotypes Through Health Administrative Data
Sep 9, 2025, 16:22 PM -
Pain and Fatigue Assessment and Evaluation in Oncology Trials
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of CKD Screening: Insights for the 60+ General Population and Those With Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
Time to and Time in Better Health States With Sotatercept for Pulmonary Arterial Hypertension: A Modeling Study
Sep 9, 2025, 16:22 PM -
Burden of Healthcare Waste for European Hospitals: Findings From an AI-Based Literature Research
Sep 9, 2025, 16:22 PM -
From Diagnosis to Treatment: Evaluating Timeliness and Treatment Patterns in Czech Pancreatic Cancer Patients
Sep 9, 2025, 16:22 PM -
Unmet Needs in Late-Line Metastatic Colorectal Cancer in Portugal: An Expert-Informed Epidemiological Forecast
Sep 9, 2025, 16:22 PM -
Real-World Evidence of Atezolizumab in Unresectable Recurrent NSCLC: Insights From Japan's Next-Generation Medical Infrastructure Act
Sep 9, 2025, 16:22 PM -
An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Sep 9, 2025, 16:22 PM -
Maximizing Profits Through Pricing: Opportunities in Portugal's Pharma Sector
Sep 9, 2025, 16:22 PM -
The Disease Burden of Respiratory Syncytial Virus Among the Adult Population in Greece
Sep 9, 2025, 16:22 PM -
Epidemiology and Demographic Characteristics of Phenylketonuria in Brazil: A Real-World Data Study (2019-2024)
Sep 9, 2025, 16:22 PM -
Trends and Characteristics of Thrombectomy Use in Acute Ischemic Stroke in Germany (2019-2024): Insights From National Claims Data
Sep 9, 2025, 16:22 PM -
Potential Nephrocalcinosis Risk Linked to Nusinersin: Insights from FAERS-Based Signal Detection and Molecular Docking
Sep 9, 2025, 16:22 PM -
The French Transitional Coverage Pathway (PECT) for Innovative Therapeutic Medical Devices: A Four-Year Retrospective Analysis
Sep 9, 2025, 16:22 PM -
Consideration of Off-Label Therapies as Appropriate Comparator Therapy in Early Benefit Assessments in Germany Under the ALBVVG Legislation
Sep 9, 2025, 16:22 PM -
Budget Impact of an Organized Diabetes Screening in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Comparative Efficacy of Asciminib vs. Second-Generation TKIs in Newly Diagnosed PhCML Using Unanchored Matching-Adjusted Indirect Comparisons
Sep 9, 2025, 16:22 PM -
Estimating the Cost-Effectiveness of Tumor-Treating Fields With Gemcitabine and Nabpaclitaxel for Frontline Treatment of Locally Advanced Pancreatic Adenocarcinoma
Sep 9, 2025, 16:22 PM -
The Health Impact of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab Treatment for High-Risk Early Stage Triple-Negative Breast Cancer (eTNBC) in Türkiye
Sep 9, 2025, 16:22 PM